Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapine With Triple Antiemetic Therapy for Prevention of Highly Emetogenic Chemo-Induced Nausea & Vomiting in Solid Tumors"
By
Insights from 2023 SABCS
FEATURING
Jyoti Bajpai
By
Insights from 2023 SABCS
FEATURING
Jyoti Bajpai
48 views
February 28, 2024
Login to view comments.
Click here to Login
Videos